B/BE/21/BVW8 - Information sheet for the public (prepared by the notifier)

Trial reference: 
Phase 3 Randomized, Controlled Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated with Variants in the RPGR gene